Related Experiment Videos

Long QT syndrome in children

J M Wu1, J N Wang, C S Lin

  • 1Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan, R.O.C. jingming@mail.ncku.edu.tw

Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
|May 1, 1997
PubMed

Insights

Long QT syndrome in children can lead to serious events like seizures and sudden death. Early diagnosis and beta-blocker treatment show promise for managing this condition, though some patients experience recurrent symptoms.

Area of Science:

  • Pediatric Cardiology
  • Clinical Electrophysiology
  • Genetics

Background:

  • Long QT syndrome (LQTS) is a cardiac channelopathy associated with risk of syncope, seizures, and sudden cardiac death.
  • Pediatric LQTS presents unique diagnostic and management challenges due to varying clinical manifestations and potential for severe outcomes.

Purpose of the Study:

  • To describe the clinical characteristics, electrocardiographic findings, and outcomes of 11 children diagnosed with Long QT syndrome.
  • To evaluate the effectiveness of beta-blocker therapy in managing pediatric LQTS.

Main Methods:

  • Retrospective review of 11 pediatric patients diagnosed with LQTS between June 1990 and June 1996.
  • Analysis of clinical presentation, corrected QT intervals (QTc), electrocardiogram (ECG) abnormalities, and treatment responses.
  • Follow-up assessment of symptom recurrence and mortality.

Main Results:

  • The study included 11 children (7 males, 4 females) aged 1 day to 13 years with QTc intervals ranging from 0.46-0.59 sec.
  • Presenting symptoms included seizures (6), syncope (3), and sudden death (2). ECG abnormalities noted were torsades de pointes (7) and sinus bradycardia (4).
  • After treatment with beta-blockers, 6 patients were symptom-free, 2 had recurrent syncope, and 1 died from ventricular tachycardia during a 0.5-6 year follow-up.

Conclusions:

  • Long QT syndrome in children presents with diverse symptoms and ECG findings, including life-threatening arrhythmias.
  • Beta-blocker therapy is a cornerstone in managing pediatric LQTS, leading to symptom resolution in a majority of cases.
  • Despite treatment, a subset of pediatric LQTS patients remain at risk for recurrent syncope and mortality, necessitating ongoing monitoring.

Related Concept Videos